Andere talen 4basebio PLC

Aandelen

Vertraagde tijd London S.E. Andere beurzen 10:00:07 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.020 ^GBX	-4,67%		-2,39%	+50,00%

10/04	4basebio levert synthetisch DNA voor mRNA-vaccinprogramma	AN
10/04	4Basebio plc kondigt de levering aan van zijn opDNA? DNA-producten aan het vaccinprogramma van een vooraanstaande farmaceutische klant	CI

4basebio to supply synthetic DNA for mRNA vaccine program	10/04
4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program	10/04
4Basebio plc Announces the Supply of Its opDNA? DNA Products into Tier 1 Pharma Client's Vaccine Program	10/04
4basebio updates markets on "key milestone" with client	21/03
4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine	21/03
Alpha Real Trust says in "robust" financial shape	01/03
4basebio wins DNA supply contract to support RNA therapies	01/03
4basebio Wins Synthetic DNA Supply Tender from CPI	01/03
4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence	01/03
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Holding(s) in Company	06/02
4basebio Plc - Exercise of Options	06/02
4basebio Plc - Holding(s) in Company	05/02
4basebio Plc - Holding(s) in Company	05/02
4basebio Plc - Holding(s) in Company	05/02
4basebio Plc - Directors' Dealings	05/02
4basebio Plc - Long-Term Incentive Plan and Exercise of Options	02/02
4basebio interim loss widens as research costs increase	21-09-23

Geen resultaten voor deze zoekopdracht